LIU Chenxia, ZHU Lili. Efficacy observation of traditional Chinese medicine decoction combined with aripiprazole in the treatment of chronic schizophrenia[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 119-122. DOI: 10.7619/jcmp.201917034
Citation: LIU Chenxia, ZHU Lili. Efficacy observation of traditional Chinese medicine decoction combined with aripiprazole in the treatment of chronic schizophrenia[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 119-122. DOI: 10.7619/jcmp.201917034

Efficacy observation of traditional Chinese medicine decoction combined with aripiprazole in the treatment of chronic schizophrenia

More Information
  • Received Date: June 16, 2019
  • Accepted Date: August 20, 2019
  • Available Online: February 28, 2021
  • Published Date: September 14, 2019
  •   Objective  To explore the clinical efficacy of traditional Chinese medicine decoction combined with aripiprazole in the treatment of chronic schizophrenia.
      Methods  Sixty patients with chronic schizophrenia were randomly divided into combined treatment group (traditional Chinese medicine decoction combined with aripiprazole) and single treatment group (aripiprazole only), with 30 cases in each group. The score of positive and negative syndrome scale (PANSS), quality of life, incidence of adverse reactions and clinical efficacy were compared between the two groups.
      Results  The scores of psychopathology, positive symptoms, negative symptoms and PANSS in both groups after treatment were significantly lower than those before treatment (P < 0.05), and the scores of items mentioned above in the combined treatment group were significantly lower than those in the single treatment group (P < 0.05). The scores of symptoms/side effects, energy/motivation, psychological/social and total score of Schizophrenia Quality of Life Scale (SQLS) in both groups after treatment were significantly lower than those before treatment (P < 0.05), and the scores of items mentioned above in the combined treatment group were significantly lower than those in the single treatment group (P < 0.05). There was no significant difference in the incidence rate of adverse reactions between the two groups (P>0.05). The total effective rate of the combined treatment group was 96.7%, which was significantly higher than 80.0% of the single treatment group (P < 0.05).
      Conclusion  Traditional Chinese medicine decoction combined with aripiprazole is effective in the treatment of chronic schizophrenia.
  • [1]
    吴启姣. 人性化护理对慢性精神分裂症患者的影响[J]. 深圳中西医结合杂志, 2016, 26(9): 166-168. https://www.cnki.com.cn/Article/CJFDTOTAL-SZZX201609083.htm
    [2]
    姚建新, 秦承花, 吴文波, 等. 社会技能训练对退伍军人慢性精神分裂症康复效果临床研究[J]. 深圳中西医结合杂志, 2016, 26(18): 14-15. https://www.cnki.com.cn/Article/CJFDTOTAL-SZZX201618007.htm
    [3]
    张永艳, 赵景新, 王秀梅, 等. 药物联合改良式森田疗法及内观疗法治疗慢性精神分裂症的临床疗效[J]. 国际精神病学杂志, 2016, 43(6): 999-1001, 1010. https://www.cnki.com.cn/Article/CJFDTOTAL-GWYJ201606011.htm
    [4]
    温紫娴, 徐敬文, 黄永烽. 优质护理服务对慢性精神分裂症患者的影响[J]. 深圳中西医结合杂志, 2015, 25(24): 172-173. https://www.cnki.com.cn/Article/CJFDTOTAL-SZZX201524089.htm
    [5]
    潘兴华, 吴淑华, 潘瑞媚, 等. 健康教育对社区慢性精神分裂症患者自知力恢复的影响[J]. 深圳中西医结合杂志, 2016, 26(10): 188-189. https://www.cnki.com.cn/Article/CJFDTOTAL-SZZX201610095.htm
    [6]
    张学斌. 金匮肾气汤加减治疗慢性精神分裂症60例[J]. 现代中医药, 2007, 27(3): 16-17. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZY200703008.htm
    [7]
    李存新, 刘飞虎, 胡海燕, 等. 氟哌啶醇穴位注射治疗精神分裂症的疗效观察[J]. 现代中医药, 2017, 37(5): 67-69. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZY201705026.htm
    [8]
    Ruiz-Iriondo M, Salaberria K, Polo-López R, et al. Preventing cognitive decline in chronic schizophrenia: Long-term effectiveness of integrated psychological therapy and emotional management training[J]. Psicothema, 2019, 31(2): 114-120. http://www.ncbi.nlm.nih.gov/pubmed/31013234
    [9]
    Benson T L, Brugger P, Park S. Bodily self-disturbance in schizophrenia-spectrum populations: Introducing the Benson et al. Body Disturbances Inventory (B-BODI)[J]. Psych J, 2019, 8(1): 110-121. doi: 10.1002/pchj.280
    [10]
    Duman R S, Sanacora G, Krystal J H. Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments[J]. Neuron, 2019, 102(1): 75-90. doi: 10.1016/j.neuron.2019.03.013
    [11]
    汪金涛, 郝秀梅. 精神分裂症可从"痰瘀"论治[J]. 世界中西医结合杂志, 2016, 11(7): 1011-1013, 1033. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX201607036.htm
    [12]
    李美娟, 石洲宝, 高娜, 等. 安神胶囊对慢性精神分裂症患者认知和社会功能的影响[J]. 西部中医药, 2015, 28(9): 1-5. doi: 10.3969/j.issn.1004-6852.2015.09.001
    [13]
    林虹, 于志峰, 王志凌, 等. 加味癫狂梦醒汤对精神分裂症脑源性神经营养因子调节的研究[J]. 中医药学报, 2014, 42(4): 153-155. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB201404057.htm
    [14]
    谢辉, 龙志江, 贺又舜. 宁神温胆汤对精神分裂症大鼠海马凋亡蛋白Fas、FasL表达的影响[J]. 中华中医药学刊, 2015, 33(2): 366-368. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201502038.htm
    [15]
    寇泽刚. 阿立哌唑、喹硫平和利培酮对精神分裂症患者甲状腺素水平的影响[J]. 蚌埠医学院学报, 2015, 40(9): 1184-1185, 1188. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201509013.htm
    [16]
    马爱清. 对比分析应用阿立哌唑与奥氮平治疗精神分裂症的临床疗效[J]. 当代医药论丛, 2014, 12(19): 150-152. doi: 10.3969/j.issn.2095-7629.2014.19.132
    [17]
    曾荟宇. 阿立哌唑、利培酮和氯氮平治疗精神分裂症的临床效果分析[J]. 中国医药科学, 2015, 5(7): 86-89. https://www.cnki.com.cn/Article/CJFDTOTAL-GYKX201507026.htm
    [18]
    王毅刚, 罗海峰, 丁振华, 等. 阿立哌唑结合奥氮平治疗精神分裂症的临床效果观察[J]. 国际精神病学杂志, 2016, 43(1): 69-72. https://www.cnki.com.cn/Article/CJFDTOTAL-GWYJ201601024.htm
    [19]
    徐海春, 张昌, 王春丽, 等. 氨磺必利与阿立哌唑治疗慢性精神分裂症的临床对照研究[J]. 中国医学创新, 2016, 13(10): 33-36. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCX201610012.htm

Catalog

    Article views (280) PDF downloads (9) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return